Lidex-E Interactions
There are 47 drugs known to interact with Lidex-E (fluocinonide topical), along with 5 disease interactions. Of the total drug interactions, 47 are moderate.
- View all 47 medications that may interact with Lidex-E
- View Lidex-E disease interactions (5)
Most frequently checked interactions
View interaction reports for Lidex-E (fluocinonide topical) and the medicines listed below.
- Alaway (ketotifen ophthalmic)
- alfuzosin
- Allegra (fexofenadine)
- amlodipine
- amoxicillin
- Anaprox-DS (naproxen)
- Aricept (donepezil)
- aspirin
- Aspirin Low Strength (aspirin)
- atorvastatin
- Brilinta (ticagrelor)
- Bydureon (exenatide)
- Bydureon BCise (exenatide)
- calcipotriene topical
- calcium carbonate
- carvedilol
- celecoxib
- Cetaphil Cleanser (emollients topical)
- cetirizine
- Cozaar (losartan)
- cyanocobalamin
- cyclobenzaprine
- diazepam
- dibucaine topical
- diclofenac
- Dovonex (calcipotriene topical)
- hydrochlorothiazide
- ketoconazole topical
- metformin
- Vitamin D3 (cholecalciferol)
Lidex-E disease interactions
There are 5 disease interactions with Lidex-E (fluocinonide topical) which include:
Report options
QR code containing a link to this page
More about Lidex-E (fluocinonide topical)
- Lidex-E consumer information
- Compare alternatives
- Reviews (1)
- Side effects
- Dosage information
- During pregnancy
- Drug class: topical steroids
- Breastfeeding
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.